Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.

Colin Widen is a dynamic leader with over 25 years of experience in the institutional asset management and life sciences sectors, specializing in capital formation, strategic financial planning, and advisory services. As Managing Member of Eden Roc Advisors, he focuses on innovative healthcare consulting, particularly in Health Care IT and Diagnostics, while also guiding Family Offices in optimizing their investment strategies. Colin's career includes leadership roles at Boston Innovation Capital and Parker Point Capital, where he raised over $1 billion and connected emerging companies with institutional investors worldwide. Known for his integrity, deep industry knowledge, and strategic vision, Colin continues to drive impactful relationships between investors and groundbreaking opportunities.

Diagnostics are the cornerstone of effective healthcare, playing a critical role in disease detection, treatment, and prevention. As advancements in diagnostic technologies continue to evolve, particularly in low-resource settings, they are transforming global health outcomes by improving access to timely and accurate disease management. Innovative tools such as point-of-care testing, mobile health devices, and genomic diagnostics are empowering healthcare providers to deliver better care, especially in underserved regions. With ongoing investments in infrastructure, training, and partnerships, diagnostics are helping to enhance disease prevention, improve treatment outcomes, and reduce healthcare costs worldwide. #Diagnostics #GlobalHealth #HealthcareInnovation #DiseaseManagement #POCT #Genomics #Telemedicine #HealthEquity